An endogenous, orally bioavailable small molecule in development for chronic liver disease and acute organ injury.
An investigational once-daily formulation of the widely-prescribed ADHD medication methylphenidate under evaluation for resistance to common methods of tampering.
An investigational non-opioid, locally-acting analgesic being evaluated for its ability to deliver 3 days of continuous pain relief after surgery.
An investigational sustained-release ophthalmology product incorporating DURECT’s SABER depot technology.
© 2000-2019 DURECT Corporation